investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia
Markus Muschen
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Warren Alexander
Walter and Eliza Hall Institute of Medical Research
Melbourne, Australia
Markus Muschen
University of California, San Francisco
San Francisco, United States
Related projects
Jerald Patrick Radich
The Genetics of Post-Transplant Relapse in Myeloid Malignancy
Leukaemia
Pathology
Giovanna Tosato
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
Leukaemia
Hematology and hematologic malignancies
Ashley Marie Pandolfi
Unraveling crucial roles of homeobox gene Hlx in hematopoiesis and leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Peter Kent Jackson
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
Trachea, bronchus and lung
Joyce M Slingerland
Effects of the PI3K Pathway on p27 Function and Cancer Progression
Breast
Paul B. Jacobsen
Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue
Leukaemia
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast
Hiroaki Mitsuya
Development of Novel Agents Active against Hepatitis B Virus
Leukaemia
Pathology
Maxwell Lee
Genetics and Epigenetics of Cancer
Breast